Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Barriers
Beyond Scholars
Community Table
GetInsulin.org
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
Technology
$10 Million Grant to ViaCyte from Gore Supports Cell-Based Treatment for Diabetes
Today, ViaCyte and W.L. Gore & Associates announced a $10 million investment by Gore into ViaCyte. This is the second multimillion dollar investment by Gore, following a first in 2017.
CRISPR Therapeutics and ViaCyte’s Strategic Collaboration to Develop Gene‐Edited Stem Cell‐Derived Therapy for Diabetes
Yesterday, CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company that develops transformative gene‐based medicines for serious diseases, and ViaCyte, Inc., a regenerative medicine company,...
DANA: The New Resource for Diabetes Educators
AADE recently announced the launch of DANA, its newest resource for AADE members. DANA (Diabetes Advanced Network Access) keeps a host of information about the latest diabetes-related technology up-to...
SGLT Trials Show Lower A1Cs, Higher Chance of DKA
The study conclusions found that Zynquista combined with optimized insulin therapy was associated with sustained A1C reduction, weight loss, lowered insulin doses, fewer episodes of severe hypoglycemi...
Next Stop Cure? A Quick History of Diabetes Research
Diabetes innovation continues to make strides each day—and we've come a long way. Curious about the history of diabetes research? Read on.
Ready-To-Use Glucagon Rescue Pen
Xeris Pharmaceuticals announced this week that the company has filed an NDA (new drug application) to the FDA for its Glucagon Rescue Pen.
The Future of OpenAPS with Dana Lewis
Beyond Type 1 recently sat down with Dana Lewis, who shared with us how the OpenAPS system has changed her life. Her diabetes journey is fascinating, and Dana gave us a behind-the-scenes look at the t...
Research for Better Management + Cure of Type 1 diabetes
Research to cure and treat Type 1 mostly fits into five areas: 1) beta cell health and regeneration, 2) immunotherapy, 3) replacement beta cells, 4) device/technology innovation and 5) medications for...
The Insulin Patch and Who Will Bring it to Market
CeQur, a company that develops and sells simple insulin delivery devices primarily for those with type 2, has recently bought the Calibra insulin delivery patch from Johnson & Johnson.
Tortoise vs the Hare – Islet Transplantation vs Technology
The race to find a more effective and non-evasive, injection-free therapy for patients with Type 1 diabetes involves many players. The remaining question is not when, but who is going to win: the tort...
Switching from a Pump to Injections
My insulin pump does so many things that multiple daily injections just can’t offer me … until I discovered the InPen! Listen to Glitter Glucose's Paloma and what she thinks about the insuli...
My 5 Disciplines for a Triathalon
When you think of the triathlon, you probably think of three disciplines - the swim, the bike and the run. There's another discipline, which is the 'transition.' I have a fifth discipl...
DugalDiabetes – A Decision Support App for Individualized Mealtime Insulin Dosing
DugalDiabetes is a decision support app focused on mealtime insulin dosing that is customized to you and your experience.
Quincy the Koala Gets a Dexcom G6 CGM
Quincy, a koala with type 1 diabetes who lives in the San Diego Zoo, just got a Dexcom G6 CGM.
New iLet Bionic Pancreas System Begins Clinical Trial Testing
Beta Bionics has officially received IDE approval from the FDA to begin a clinical trial, testing the new iLet Bionic Pancreas System.
Posts navigation
←
Newer
Posts
1
…
7
8
9
…
12
Older
Posts
→